Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Jean Paul Myne' Srl currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single pending action represents the entirety of the company's current active prosecution workload. The focus on this specific technology area indicates that the company's intellectual property efforts are concentrated in the Biotechnology & Pharmaceuticals sector.
The portfolio's prosecution is distributed across 1 distinct examiner and 1 distinct art unit. Having only 1 distinct art unit involved suggests a narrow technical focus for the pending matters. This centralization allows the company to navigate the specific procedures and interpretations of the assigned art unit without facing conflicting requirements from other units.
ALISSA J PROSSER is identified as the busiest examiner for this portfolio, currently handling 1 busiest examiner pending office action. This examiner is responsible for all pending actions reported in the data. Practitioners can focus their strategy on the specific tendencies and past decisions of this individual examiner to address the 1 pending office action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PROSSER, ALISSA J | 1 | 15.7% | +11.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18251684 | COSMETIC COMPOSITION FOR THE TREATMENT OF KERATINIC FIBERS AND METHOD COMPRISING THE APPLICATION OF SAID COMPOSITION TO THE KERATINIC FIBERS | PROSSER, ALISSA J | 33d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18251684 | COSMETIC COMPOSITION FOR THE TREATMENT OF KERATINIC FIBERS AND METHOD COMPRISING THE APPLICATION OF SAID COMPOSITION TO THE KERATINIC FIBERS | PROSSER, ALISSA J | 33d |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18251684 | COSMETIC COMPOSITION FOR THE TREATMENT OF KERATINIC FIBERS AND METHOD COMPRISING THE APPLICATION OF SAID COMPOSITION TO THE KERATINIC FIBERS | PROSSER, ALISSA J | 1619 | §103§112 | Non-Final OA | 33d | Pending | May 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial